-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Thailand's nasal spray new crown vaccine is expected to enter clinical trials by the end of the year |
Xinhua News Agency, Bangkok, August 11 (Ren Qian) The National Science and Technology Development Agency of Thailand recently announced that the two nasal spray vaccines developed by the agency against the new coronavirus are expected to enter phase I clinical trials by the end of this year
.
The National Science and Technology Development Agency of Thailand said in a statement on the 10th that the two nasal spray new crown vaccines independently developed by the National Genetic Engineering and Biotechnology Research Center under the agency have now completed the animal experiment stage and have good results.
They will be sent to Thailand in the near future.
The Food and Drug Administration of the Ministry of Health applied for clinical trials
.
The research center's vaccine research director Anan Kewatana said that the two nasal spray vaccines are adenovirus vector vaccines and attenuated influenza virus vector vaccines
.
Animal experiments have shown that both vaccines have successfully caused the experimental mice to produce an immune response against the new coronavirus
Anan also said that the researchers will also test the effectiveness of the two vaccines against the Delta strain.
Focus on the new crown pneumonia epidemic